ENVESTNET ASSET MANAGEMENT INC - TURNING POINT THERAPEUTICS I ownership

TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 206 filers reported holding TURNING POINT THERAPEUTICS I in Q1 2021. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.

Quarter-by-quarter ownership
ENVESTNET ASSET MANAGEMENT INC ownership history of TURNING POINT THERAPEUTICS I
ValueSharesWeighting
Q2 2022$448,000
+83.6%
5,954
+16.6%
0.00%
Q4 2021$244,000
+0.4%
5,106
+39.4%
0.00%
Q3 2021$243,000
-7.6%
3,663
+8.5%
0.00%
Q2 2021$263,000
-11.4%
3,376
+7.6%
0.00%
Q1 2021$297,000
-32.5%
3,138
-13.1%
0.00%
Q4 2020$440,000
+52.8%
3,613
+9.8%
0.00%
Q3 2020$288,0003,2910.00%
Other shareholders
TURNING POINT THERAPEUTICS I shareholders Q1 2021
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 2,737,297$176,802,0006.75%
MPM BioImpact LLC 308,686$19,938,0005.30%
Burrage Capital Management LLC 77,172$4,985,0003.49%
Orbimed Advisors 2,745,327$177,321,0002.50%
Parkman Healthcare Partners LLC 110,318$7,125,0002.01%
SECTORAL ASSET MANAGEMENT INC 284,486$18,375,0001.69%
First Light Asset Management, LLC 192,829$12,455,0001.45%
Asymmetry Capital Management, L.P. 22,608$1,460,0001.12%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 35,000$2,236,0000.74%
Prosight Management, LP 25,602$1,654,0000.71%
View complete list of TURNING POINT THERAPEUTICS I shareholders